BCG revaccination qualitatively and quantitatively enhances SARS-CoV-2 spike-specific neutralizing antibody and T cell responses induced by the COVISHIELD(™) vaccine in SARS-CoV-2 seronegative young Indian adults

This study tested if prior BCG revaccination can further boost immune responses subsequently induced by a widely distributed and otherwise efficacious Oxford/AstraZeneca ChAdOx1nCoV-19 vaccine, referred to as COVISHIELD(™), in India. We compared COVISHIELD(™) induced longitudinal immune responses in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakshit, Srabanti, Adiga, Vasista, Ahmed, Asma, Parthiban, Chaitra, Kumar, Nirutha Chetan, Dwarkanath, Pratibha, Shivalingaiah, Sudarshan, Rao, Srishti, D’Souza, George, Dias, Mary, Maguire, Thomas J.A., Doores, Katie, Dasgupta, Prokar, Babji, Sudhir, Ottenhoff, Tom H.M, Stuart, Kenneth D., De Rosa, Stephen, McElrath, M. Juliana, Vyakarnam, Annapurna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902867/
https://www.ncbi.nlm.nih.gov/pubmed/35262071
http://dx.doi.org/10.21203/rs.3.rs-1395683/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902867/
https://www.ncbi.nlm.nih.gov/pubmed/35262071
http://dx.doi.org/10.21203/rs.3.rs-1395683/v1

Ejemplares similares